Brain Health Devices Market Synopsis:
\nBrain Health Devices Market Size Was Valued at USD 15.12 Billion in 2023, and is Projected to Reach USD 31.51 Billion by 2032, Growing at a CAGR of 8.5% From 2024-2032.
\nThe Brain Health Devices Market includes a broad spectrum of medical devices that can diagnose, treat, and observe or manage neurological and psychiatric disorders. See also: Advanced technology devices to help doctors in checking the condition of the brain in real-time besides helping in the treatment of the conditions like traumatic brain injuries, neurodegenerative disorders, and epilepsy. Major factors consist of technological development, growing incidences of neurological disorders and a push toward non-invasive treatment solutions.
\nThe Brain Health Devices Market has expanded rapidly in the last few years on account to the rising number of neurological disorders as well as rising consumer consciousness about their brain health. Medical disorders of the brain and mind such as Alzheimer\u2019s disease, Parkinson\u2019s disease, epilepsy, and head injury have increasing prevalence rates globally. Consequently, there has been an extended need for gadgets that maybe used to screen, identify, and manage these diseases. Including neurostimulation and brain imaging equipment, EEG\/MEG products that are used clinically or in research. Various examples of self-regulation technologies are neurostimulation devices whose therapy involves the application of electricity to specific parts of the brain which can be of help to patients with conditions such as epilepsy and depression.
\nThe increasing improvements in technology have seen the development. Endpoint settings and home settings have also embraced the use of these devices rather than operating in a hospital alone. For instance, the reduction of the size of the equipment and the integration of artificial intelligence and machine learning in diagnosis are helpful in making accurate diagnosis as well as selection of fine treatment plan for the patient. The diagnostic and prognostic applications of imaging devices and EEG\/MEG are most important in the context of disease progression and neurological deterioration. That is why such technologies help healthcare providers to offer early and more efficient treatments. Since almost all healthcare systems nowadays attach importance to prevention over cure, there is a trend towards brain wellness as an important aspect of personal health. Therefore, there are high prospects for the development of the brain health devices market as part of the larger trends in specific and preventive medicine.<\/p>\n
Brain Health Devices Market Trend Analysis:
\nIncreasing Adoption of Portable and Wearable Brain Health Devices<\/p>\n
Along with enhancement in portable technology, trend of portable and wearable brain health devices has been observed and is being used more frequently in clinical as well as consumer domain. These devises also include the health and brain activity and the need to constantly monitor such an important part of their body means that a person can now do so without having to do so in clinical settings. For instance, there are now wearable EEGs that clients suffering from epilepsy can wear at home, and send their results to the clinic. This trend corresponds to general tendencies of the shift to telemedicine and remote patient monitoring that has become even more important after COVID-19.<\/p>\n
In addition, these transportation able devices are growing embedding AI and machine learning that boosts data and diagnostic efficiency. These advanced technologies make it possible to implement the devices in a way that such devices are able to offer more personalized information on the patient due to unique data pertaining to the patient. Therefore, knowledge transformation enables patient and health care provider autonomy regarding neurological disease, decision making as they occur as it embeds real time data analysis. It therefore not only enhances patients\u2019 compliance, but also makes way for more effective and even more preventive \u2018wearable\u2019 approach to the brain health.
\nExpansion of Brain Health Devices for Mental Health Applications<\/p>\n
The entrance of the brain health devices into the mental health segment is an opportunity that could be exploited. While the general population around the world is becoming more sensitized to mental illnesses, there is a growing call for equipment usable in identifying and treating diseases like the depression, anxiety, and PTSD. Implantable neurostimulation devices such as TMS or other non-invasive neurostimulation methods have revealed positive evidence in the treatment of TRD. These devices are in my opinion less dangerous and quite often more efficient than medications particularly for people, who do not have positive reaction to tablets.<\/p>\n
Besides, given that mental health disorders are some of the main causes of disability, the utilization of brain health devices offers a massive opportunity for enhanced treatment. New brain imaging and EEG devices which are in the development can trace the brain activities linked to mental disorders for optimal management. It goes without saying that, as healthcare providers realize the benefits of utilizing brain health devices while treating mental disorders, market potential broadens when it is fueled by the higher consciousness of mental health and progressive legislation in relevant territories.
\nBrain Health Devices Market Segment Analysis:
\nBrain Health Devices Market is Segmented on the basis of Product Type, Application, End User, and Region
\nBy Product Type, Neurostimulation Devices segment is expected to dominate the market during the forecast period<\/p>\n
The market can be defined as the one that consists of a vast number of products that play different roles in connection with the brain. Neurostimulation devices are more and more applied for the management of several neurological disorders by using electrical or magnetic stimulus on definite areas of the brain. Especially, those conditions like depression and epilepsy being treated with these devices exhibit improved results as compared to regular medications. MRI and CT scanners are two major imaging apparatuses used in the diagnosis of neurological disorders elucidating structural and functional dysfunctions of the brain. This in turn is expected to make the production of such imaging devices popular because the number of people suffering from neurodegenerative diseases is constantly rising.<\/p>\n
EEG and MEG devices are also an essential element of the market serving to monitor the brain and abnormal electrical patterns associated with epilepsy and other neurological disorders. EEG devices are more common as they are inexpensive and portable compared to MEG devices, which although are larger and expensive give higher localization accuracy. This diversified product portfolio shows that the market for brain health devices can help patients with brain disorders at every stage of the care continuum from diagnosis to chronic disease management.
\nBy Application, Traumatic Brain Injury (TBI) segment expected to held the largest share <\/p>\n
The neurological disorder supporting devices are useful in several neurological disorders, but the most substantial areas include TBI and stroke. Traumatic brain injury cases especially those resulting from athletic activities and or accident needs constant tracking, standard tools here include EEG and brain imaging. In the same way, for stroke management, bad are also very much involved for assessing the progress of the recovery and preventing further strokes. An increase of frequency of stroke and TBI act as additional boosters towards the need of using these devices in the healthcare facilities.<\/p>\n
In the case of Alzheimer and Parkinson and other Neurodegenerative diseases, Biomarkers especially brain imaging devices are used in screening and detection of the ailment and follow up. Besides, the usage of brain health devices in epilepsy treatment is well understood, for example EEG devices are fundamental to seizure monitoring and management. Therefore, the relevance of brain health devices is becoming apparent in various neurological instances as the incidence of valuable ailments grows.
\nBrain Health Devices Market Regional Insights:
\nNorth America is Expected to Dominate the Market Over the Forecast period <\/p>\n
North America has currently the largest share in the brain health devices market due to well developed healthcare sector coupled with high spending on healthcare. Investment on R&D for medical devices associated with neurological disorders is high in the region due to high prevalence rate. Moreover, the reimbursement policies of North America remain beneficial for brain health technologies, and this region has a stable regulatory framework that entails encouraging changes in technologies in the field of brain health. Combined with these factors give North America the position of the market leader.<\/p>\n
In addition, the region is much more inclined toward the implementation of such state-of-art solutions, as AI and machine learning for brain health devices that help to provide more precise diagnostics and effective treatments. The predominance of important manufacturers and research centres also testifies to the fact that North America remains one of the leading markets for brain health devices. Market research, increasing concerns for mental and brain health, and growing population can continue to drive North America\u2019s growth in the future.
\nActive Key Players in the Brain Health Devices Market: <\/p>\n
Medtronic (Ireland)<\/p>\n
Boston Scientific Corporation (USA)<\/p>\n
GE Healthcare (USA)<\/p>\n
Siemens Healthineers (Germany)<\/p>\n
Koninklijke Philips N.V. (Netherlands)<\/p>\n
Nihon Kohden Corporation (Japan)<\/p>\n
NeuroPace, Inc. (USA)<\/p>\n
Magstim (UK)<\/p>\n
Elekta AB (Sweden)<\/p>\n
Natus Medical Incorporated (USA)<\/p>\n
Masimo Corporation (USA)<\/p>\n
Compumedics Limited (Australia)<\/p>\n
Other Active Players
\nKey Industry Developments in the Brain Health Devices Market:<\/p>\n
In January 2024, Medtronic plc announced that the U.S. Food and Drug Administration (FDA) had approved its Percept RC Deep Brain Stimulation (DBS) system. This rechargeable neurostimulator is the latest innovation in the Medtronic Percept range, which includes the Percept PC neurostimulator, BrainSense technology, and SenSight directional leads. The Percept range is the only sensing-enabled DBS system available, enabling physicians to personalize treatment for patients with movement disorders such as Parkinson’s disease, essential tremor, and dystonia, as well as epilepsy.<\/p>\n
In November 2023, Advanced Brain Monitoring, Inc. announced the integration of its mobile, wireless, 24-channel EEG system with the Stratus EEG cloud-based clinical software platform for home or hospital seizure monitoring. ABM has pioneered the development of lightweight, easy-to-use systems for acquiring and analyzing EEG, ECG, EMG, and other physiological signals. Stratus’ expertise in scaling clinical EEG and assessing seizures and other EEG abnormalities will enhance ABM’s NIH-funded research programs, including longitudinal studies on neurodegenerative diseases such as Alzheimer’s, Lewy Body, and Parkinson’s dementias.<\/p>\n
In March 2023, Compumedics Limited announced that it had received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Okti high-density EEG amplifier range. Okti represents the culmination of decades of expertise in EEG monitoring and a deep understanding of patient care. It is the world’s first high-density ambulatory EEG amplifier of its kind, and it can also be used for routine and long-term EEG epilepsy monitoring (LTM).<\/p>\n","protected":false},"excerpt":{"rendered":"
The Brain Health Devices Market includes a broad spectrum of medical devices that can diagnose, treat, and observe or manage neurological and psychiatric disorders. See also: Advanced technology devices to help doctors in checking the condition of the brain in real-time besides helping in the treatment of the conditions like traumatic brain injuries, neurodegenerative disorders, and epilepsy.<\/p>\n","protected":false},"featured_media":23768,"template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[194],"product_tag":[],"class_list":["post-26577","product","type-product","status-publish","has-post-thumbnail","product_cat-healthcare-life-sciences","first","instock","virtual","purchasable","product-type-simple"],"acf":[],"yoast_head":"\n